Oncology clinical trials /
Clinical trials are the engine of progress in the development of new drugs and devices for the detection, monitoring, prevention and treatment of cancer. A well conceived, carefully designed and efficiently conducted clinical trial can produce results that change clinical practice overnight, deliver...
Clasificación: | Libro Electrónico |
---|---|
Otros Autores: | , |
Formato: | Electrónico eBook |
Idioma: | Inglés |
Publicado: |
New York :
Demos Medical,
©2010.
|
Temas: | |
Acceso en línea: | Texto completo |
Tabla de Contenidos:
- Foreword; Preface; Contributors; 1. Introduction: What Is a Clinical Trial?; 2. Historical Perspectives of Oncology Clinical Trials; 3. Ethical Principles Guiding Clinical Research; 4. Preclinical Drug Assessment; 5. Formulating the Question and Objectives; 6. Choice of Endpoints in Cancer Clinical Trials; 7. Design, Testing, and Estimation in Clinical Trials; 8. Design of Phase I Trials; 9. Design of Phase II Trials; 10. Randomization; 11. Design of Phase III Trials; 12. Multiple Treatment Arm Trials; 13. Noninferiority Trials in Oncology; 14. Bayesian Designs in Clinical Trials
- 15. The Trials and Tribulations of Writing an Investigator Initiated Clinical Study16. Data Collection; 17. Reporting of Adverse Event; 18. Toxicity Monitoring: Why, What, When?; 19. Interim Analysis of Phase III Trials; 20. Interpretation of Results: Data Analysis and Reporting of Results; 21. Statistical Considerations for Assessing Prognostic Factors in Cancer; 22. Pitfalls in Oncology Clinical Trial Designs and Analysis; 23. Biomarkers and Surrogate Endpoints in Clinical Trials; 24. Use of Genomics in Therapeutic Clinical Trials; 25. Imaging in Clinical Trials
- 26. Pharmacokinetic and Pharmacodynamic Monitoring in Clinical Trials: When Is It Needed?27. Practical Design and Analysis Issues of Health Related Quality of Life Studies in International Randomized Controlled Cancer Clinical Trials; 28. Clinical Trials Considerations in Special Populations; 29. A Critical Reader's Guide to Cost-Effectiveness Analysis; 30. Systemic Review and Meta-Analysis; 31. Regulatory Affairs: The Investigator-Initiated Oncology Trial; 32. The Drug Evaluation Process in Oncology: FDA Perspective; 33. Industry Collaboration in Cancer Clinical Trials
- 34. Defining the Roles and Responsibilities of Study Personnel35. Writing a Consent Form; 36. How Cooperative Groups Function; 37. Adaptive Clinical Trial Design in Oncology; 38. Where Do We Need to Go with Clinical Trials in Oncology?; Index